Skip to main content
EJNMMI Reports
Fig. 3 | European Journal of Hybrid Imaging

Fig. 3

From: Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation

Fig. 3

Kaplan-Meier overall survival curves of the validation dataset of 44 patients with TNM stage 3B NSCLC, stratified by the median MTVwb of the training dataset, 85.6Ā mL. The dashed line represents the patient group with MTVwb ā‰„85.6Ā ml with median OS of 13.9Ā months. The solid line represents the patient group with MTVwb <85.6Ā ml with median OS not reached during follow-up period. The groups were significantly different with pĀ =Ā 0.03

Back to article page